Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry.

Billings CG, Lewis R, Hurdman JA, Condliffe R, Elliot CA, Thompson AAR, Smith IA, Austin M, Armstrong IJ, Hamilton N, Charalampopoulos A, Sabroe I, Swift AJ, Rothman AM, Wild JM, Lawrie A, Waterhouse JC, Kiely DG.

Pulm Circ. 2019 Apr-Jun;9(2):2045894019848649. doi: 10.1177/2045894019848649.

2.

Monitoring Training Loads and Perceived Stress in Young Elite University Athletes.

Hamlin MJ, Wilkes D, Elliot CA, Lizamore CA, Kathiravel Y.

Front Physiol. 2019 Jan 29;10:34. doi: 10.3389/fphys.2019.00034. eCollection 2019.

3.

Diagnostic and prognostic significance of cardiovascular magnetic resonance native myocardial T1 mapping in patients with pulmonary hypertension.

Saunders LC, Johns CS, Stewart NJ, Oram CJE, Capener DA, Puntmann VO, Elliot CA, Condliffe RC, Kiely DG, Graves MJ, Wild JM, Swift AJ.

J Cardiovasc Magn Reson. 2018 Dec 3;20(1):78. doi: 10.1186/s12968-018-0501-8.

4.

Perceived treadmill function is correlated with enjoyment of use in trained runners: A user-centred approach.

Carraro A, Elliot CA, Gobbi E.

Appl Ergon. 2019 Jan;74:37-40. doi: 10.1016/j.apergo.2018.08.015. Epub 2018 Aug 14.

PMID:
30487107
5.

The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension.

Quadery SR, Swift AJ, Billings CG, Thompson AAR, Elliot CA, Hurdman J, Charalampopoulos A, Sabroe I, Armstrong IJ, Hamilton N, Sephton P, Garrad S, Pepke-Zaba J, Jenkins DP, Screaton N, Rothman AM, Lawrie A, Cleveland T, Thomas S, Rajaram S, Hill C, Davies C, Johns CS, Wild JM, Condliffe R, Kiely DG.

Eur Respir J. 2018 Sep 16;52(3). pii: 1800589. doi: 10.1183/13993003.00589-2018. Print 2018 Sep.

6.

Incremental Shuttle Walking Test Distance Is Reduced in Patients With Pulmonary Hypertension in World Health Organisation Functional Class I.

Billings CG, Lewis R, Armstrong IJ, Hurdman JA, Smith IA, Austin M, Elliot CA, Charalampopoulos A, Sabroe I, Lawrie A, Thompson AAR, Condliffe R, Kiely DG.

Front Med (Lausanne). 2018 Jun 21;5:172. doi: 10.3389/fmed.2018.00172. eCollection 2018.

7.

CT derived left atrial size identifies left heart disease in suspected pulmonary hypertension: Derivation and validation of predictive thresholds.

Currie BJ, Johns C, Chin M, Charalampopolous T, Elliot CA, Garg P, Rajaram S, Hill C, Wild JW, Condliffe RA, Kiely DG, Swift AJ.

Int J Cardiol. 2018 Jun 1;260:172-177. doi: 10.1016/j.ijcard.2018.02.114. Epub 2018 Mar 4.

9.

Combining creative writing and narrative analysis to deliver new insights into the impact of pulmonary hypertension.

Goddard JC, Armstrong IJ, Kiely DG, Elliot CA, Charalampopoulos A, Condliffe R, Stone BJ, Sabroe I.

BMJ Open Respir Res. 2017 Jun 5;4(1):e000184. doi: 10.1136/bmjresp-2017-000184. eCollection 2017.

10.

Validity and Reliability of the Hexoskin Wearable Biometric Vest During Maximal Aerobic Power Testing in Elite Cyclists.

Elliot CA, Hamlin MJ, Lizamore CA.

J Strength Cond Res. 2019 May;33(5):1437-1444. doi: 10.1519/JSC.0000000000002005.

PMID:
28759538
11.

Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study.

Rhodes CJ, Wharton J, Ghataorhe P, Watson G, Girerd B, Howard LS, Gibbs JSR, Condliffe R, Elliot CA, Kiely DG, Simonneau G, Montani D, Sitbon O, Gall H, Schermuly RT, Ghofrani HA, Lawrie A, Humbert M, Wilkins MR.

Lancet Respir Med. 2017 Sep;5(9):717-726. doi: 10.1016/S2213-2600(17)30161-3. Epub 2017 Jun 15.

12.

Incremental shuttle walk test distance and autonomic dysfunction predict survival in pulmonary arterial hypertension.

Billings CG, Hurdman JA, Condliffe R, Elliot CA, Smith IA, Austin M, Armstrong IJ, Hamilton N, Charalampopoulos A, Sabroe I, Swift AJ, Rothman AM, Wild JM, Lawrie A, Waterhouse JC, Kiely DG.

J Heart Lung Transplant. 2017 Aug;36(8):871-879. doi: 10.1016/j.healun.2017.04.008. Epub 2017 Apr 24.

13.

Hypoxic Repeat Sprint Training Improves Rugby Player's Repeated Sprint but Not Endurance Performance.

Hamlin MJ, Olsen PD, Marshall HC, Lizamore CA, Elliot CA.

Front Physiol. 2017 Feb 7;8:24. doi: 10.3389/fphys.2017.00024. eCollection 2017.

14.

Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.

Ramjug S, Hussain N, Hurdman J, Billings C, Charalampopoulos A, Elliot CA, Kiely DG, Sabroe I, Rajaram S, Swift AJ, Condliffe R.

Chest. 2017 Jul;152(1):92-102. doi: 10.1016/j.chest.2017.02.010. Epub 2017 Feb 20.

PMID:
28223154
15.

Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.

Sithamparanathan S, Nair A, Thirugnanasothy L, Coghlan JG, Condliffe R, Dimopoulos K, Elliot CA, Fisher AJ, Gaine S, Gibbs JSR, Gatzoulis MA, E Handler C, Howard LS, Johnson M, Kiely DG, Lordan JL, Peacock AJ, Pepke-Zaba J, Schreiber BE, Sheares KKK, Wort SJ, Corris PA; National Pulmonary Hypertension Service Research Collaboration of the United Kingdom and Ireland.

J Heart Lung Transplant. 2017 Jul;36(7):770-779. doi: 10.1016/j.healun.2016.12.014. Epub 2016 Dec 31.

PMID:
28190786
16.

Bosutinib therapy resulting in severe deterioration of pre-existing pulmonary arterial hypertension.

Hickey PM, Thompson AA, Charalampopoulos A, Elliot CA, Hamilton N, Kiely DG, Lawrie A, Sabroe I, Condliffe R.

Eur Respir J. 2016 Nov;48(5):1514-1516. doi: 10.1183/13993003.01004-2016. Epub 2016 Sep 22. No abstract available.

17.

Long-term outcomes of domiciliary intravenous iloprost in idiopathic and connective tissue disease-associated pulmonary arterial hypertension.

Ramjug S, Hussain N, Hurdman J, Elliot CA, Sabroe I, Armstrong IJ, Billings C, Hamilton N, Kiely DG, Condliffe R.

Respirology. 2017 Feb;22(2):372-377. doi: 10.1111/resp.12899. Epub 2016 Sep 20.

PMID:
27651181
18.

Long-term effectiveness of the New Zealand Green Prescription primary health care exercise initiative.

Hamlin MJ, Yule E, Elliot CA, Stoner L, Kathiravel Y.

Public Health. 2016 Nov;140:102-108. doi: 10.1016/j.puhe.2016.07.014. Epub 2016 Aug 25.

PMID:
27569778
19.

Pulmonary hypertension in patients with heart failure and preserved ejection fraction: differential diagnosis and management.

Hussain N, Charalampopoulos A, Ramjug S, Condliffe R, Elliot CA, O'Toole L, Swift A, Kiely DG.

Pulm Circ. 2016 Mar;6(1):3-14. doi: 10.1086/685021. Review.

20.

Pulmonary arterial hypertension associated with congenital heart disease: Comparison of clinical and anatomic-pathophysiologic classification.

Ramjug S, Hussain N, Hurdman J, Billings C, Charalampopoulos A, Elliot CA, Sabroe I, Kiely DG, Condliffe R.

J Heart Lung Transplant. 2016 May;35(5):610-8. doi: 10.1016/j.healun.2015.12.016. Epub 2016 Jan 7.

PMID:
26880324
21.

Pulmonary artery denervation reduces pulmonary artery pressure and induces histological changes in an acute porcine model of pulmonary hypertension.

Rothman AM, Arnold ND, Chang W, Watson O, Swift AJ, Condliffe R, Elliot CA, Kiely DG, Suvarna SK, Gunn J, Lawrie A.

Circ Cardiovasc Interv. 2015 Nov;8(11):e002569. doi: 10.1161/CIRCINTERVENTIONS.115.002569.

22.

Management of acute pulmonary embolism.

Quadery R, Elliot CA, Hurdman J, Kiely DG, Maclean RM, Sabroe I, van Veen JJ, Condliffe R.

Br J Hosp Med (Lond). 2015 Oct;76(10):C150-5. doi: 10.12968/hmed.2015.76.10.C150. No abstract available.

PMID:
26457952
23.

CT features of pulmonary arterial hypertension and its major subtypes: a systematic CT evaluation of 292 patients from the ASPIRE Registry.

Rajaram S, Swift AJ, Condliffe R, Johns C, Elliot CA, Hill C, Davies C, Hurdman J, Sabroe I, Wild JM, Kiely DG.

Thorax. 2015 Apr;70(4):382-7. doi: 10.1136/thoraxjnl-2014-206088. Epub 2014 Dec 18.

24.

Magnetic resonance imaging of ventilation and perfusion changes in response to pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.

Marshall H, Kiely DG, Parra-Robles J, Capener D, Deppe MH, van Beek EJ, Swift AJ, Rajaram S, Hurdman J, Condliffe R, Elliot CA, Wild JM.

Am J Respir Crit Care Med. 2014 Sep 1;190(5):e18-9. doi: 10.1164/rccm.201310-1842IM. No abstract available.

25.

Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia.

Corte TJ, Keir GJ, Dimopoulos K, Howard L, Corris PA, Parfitt L, Foley C, Yanez-Lopez M, Babalis D, Marino P, Maher TM, Renzoni EA, Spencer L, Elliot CA, Birring SS, O'Reilly K, Gatzoulis MA, Wells AU, Wort SJ; BPHIT Study Group.

Am J Respir Crit Care Med. 2014 Jul 15;190(2):208-17. doi: 10.1164/rccm.201403-0446OC.

26.

Ambrisentan therapy in pulmonary hypertension: clinical use and tolerability in a referral centre.

Condliffe R, Elliot CA, Hurdman J, Sabroe I, Billings C, Kiely DG, Hamilton N.

Ther Adv Respir Dis. 2014 Jun;8(3):71-77. Epub 2014 Apr 30.

PMID:
24787237
27.

Management dilemmas in acute pulmonary embolism.

Condliffe R, Elliot CA, Hughes RJ, Hurdman J, Maclean RM, Sabroe I, van Veen JJ, Kiely DG.

Thorax. 2014 Feb;69(2):174-80. doi: 10.1136/thoraxjnl-2013-204667. Epub 2013 Dec 16. Review.

28.

Pregnancy and pulmonary hypertension: a practical approach to management.

Kiely DG, Condliffe R, Wilson VJ, Gandhi SV, Elliot CA.

Obstet Med. 2013 Dec;6(4):144-54. doi: 10.1177/1753495X13495193. Epub 2013 Aug 8. Review.

29.

Primary pulmonary artery sarcoma and coexisting chronic thromboembolic pulmonary hypertension.

Rajaram S, Swift AJ, Davies C, Hill C, Jenkins D, Goddard M, Condliffe R, Elliot CA, Wild JM, Kiely DG.

Am J Respir Crit Care Med. 2013 Sep 1;188(5):e7-8. doi: 10.1164/rccm.201210-1838IM. No abstract available.

PMID:
23992597
30.

Pulmonary hypertension: diagnosis and management.

Kiely DG, Elliot CA, Sabroe I, Condliffe R.

BMJ. 2013 Apr 16;346:f2028. doi: 10.1136/bmj.f2028. No abstract available.

PMID:
23592451
31.

Central venous catheter-related blood stream infections in patients receiving intravenous iloprost for pulmonary hypertension.

Sammut D, Elliot CA, Kiely DG, Armstrong IJ, Martin L, Wilkinson J, Sephton P, Jones J, Hamilton N, Hurdman J, McLellan E, Sabroe I, Condliffe R.

Eur J Clin Microbiol Infect Dis. 2013 Jul;32(7):883-9. doi: 10.1007/s10096-013-1822-z. Epub 2013 Feb 7.

PMID:
23388830
32.

Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension.

Rhodes CJ, Wharton J, Boon RA, Roexe T, Tsang H, Wojciak-Stothard B, Chakrabarti A, Howard LS, Gibbs JS, Lawrie A, Condliffe R, Elliot CA, Kiely DG, Huson L, Ghofrani HA, Tiede H, Schermuly R, Zeiher AM, Dimmeler S, Wilkins MR.

Am J Respir Crit Care Med. 2013 Feb 1;187(3):294-302. doi: 10.1164/rccm.201205-0839OC. Epub 2012 Dec 6.

PMID:
23220912
33.

Pulmonary hypertension in COPD: results from the ASPIRE registry.

Hurdman J, Condliffe R, Elliot CA, Swift A, Rajaram S, Davies C, Hill C, Hamilton N, Armstrong IJ, Billings C, Pollard L, Wild JM, Lawrie A, Lawson R, Sabroe I, Kiely DG.

Eur Respir J. 2013 Jun;41(6):1292-301. doi: 10.1183/09031936.00079512. Epub 2012 Sep 27.

34.

Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland.

Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JS, Howard LS, Pepke-Zaba J, Sheares KK, Corris PA, Fisher AJ, Lordan JL, Gaine S, Coghlan JG, Wort SJ, Gatzoulis MA, Peacock AJ.

Am J Respir Crit Care Med. 2012 Oct 15;186(8):790-6. doi: 10.1164/rccm.201203-0383OC. Epub 2012 Jul 12.

PMID:
22798320
35.

Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry.

Swift AJ, Rajaram S, Condliffe R, Capener D, Hurdman J, Elliot CA, Wild JM, Kiely DG.

J Cardiovasc Magn Reson. 2012 Jun 21;14:40. doi: 10.1186/1532-429X-14-40.

36.

Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease.

Rajaram S, Swift AJ, Capener D, Elliot CA, Condliffe R, Davies C, Hill C, Hurdman J, Kidling R, Akil M, Wild JM, Kiely DG.

J Rheumatol. 2012 Jun;39(6):1265-74. doi: 10.3899/jrheum.110987. Epub 2012 May 15.

PMID:
22589263
37.

Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension.

Condliffe R, Pickworth JA, Hopkinson K, Walker SJ, Hameed AG, Suntharaligam J, Soon E, Treacy C, Pepke-Zaba J, Francis SE, Crossman DC, Newman CM, Elliot CA, Morton AC, Morrell NW, Kiely DG, Lawrie A.

Pulm Circ. 2012 Jan-Mar;2(1):21-7. doi: 10.4103/2045-8932.94819.

38.

Undergraduate physical activity and depressive symptoms: a national study.

Elliot CA, Kennedy C, Morgan G, Anderson SK, Morris D.

Am J Health Behav. 2012 Mar;36(2):230-41. doi: 10.5993/AJHB.36.2.8.

PMID:
22370260
39.

Black blood MRI has diagnostic and prognostic value in the assessment of patients with pulmonary hypertension.

Swift AJ, Rajaram S, Marshall H, Condliffe R, Capener D, Hill C, Davies C, Hurdman J, Elliot CA, Wild JM, Kiely DG.

Eur Radiol. 2012 Mar;22(3):695-702. doi: 10.1007/s00330-011-2306-0. Epub 2011 Oct 13.

PMID:
21993983
40.

ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre.

Hurdman J, Condliffe R, Elliot CA, Davies C, Hill C, Wild JM, Capener D, Sephton P, Hamilton N, Armstrong IJ, Billings C, Lawrie A, Sabroe I, Akil M, O'Toole L, Kiely DG.

Eur Respir J. 2012 Apr;39(4):945-55. doi: 10.1183/09031936.00078411. Epub 2011 Sep 1.

41.

CT pulmonary angiography combined with echocardiography in suspected systemic sclerosis-associated pulmonary arterial hypertension.

Condliffe R, Radon M, Hurdman J, Davies C, Hill C, Akil M, Guarasci F, Rajaram S, Swift AJ, Wragg Z, van Beek E, Elliot CA, Kiely DG.

Rheumatology (Oxford). 2011 Aug;50(8):1480-6. doi: 10.1093/rheumatology/ker114. Epub 2011 Mar 29.

PMID:
21447566
42.

Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach.

Kiely DG, Condliffe R, Webster V, Mills GH, Wrench I, Gandhi SV, Selby K, Armstrong IJ, Martin L, Howarth ES, Bu'lock FA, Stewart P, Elliot CA.

BJOG. 2010 Apr;117(5):565-74. doi: 10.1111/j.1471-0528.2009.02492.x.

43.

Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension.

Hagger D, Condliffe R, Woodhouse N, Elliot CA, Armstrong IJ, Davies C, Hill C, Akil M, Wild JM, Kiely DG.

Rheumatology (Oxford). 2009 Sep;48(9):1137-42. doi: 10.1093/rheumatology/kep187. Epub 2009 Jul 14.

PMID:
19605369
44.

Asymptomatic bronchial aspiration and retention of a capsule endoscope.

Leeds JS, Chew TS, Sidhu R, Elliot CA, Sanders DS, McAlindon ME.

Gastrointest Endosc. 2009 Mar;69(3 Pt 1):561-2. doi: 10.1016/j.gie.2008.09.044. Epub 2008 Dec 5. No abstract available.

PMID:
19058800
45.

Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.

Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, Das C, Elliot CA, Johnson M, DeSoyza J, Torpy C, Goldsmith K, Hodgkins D, Hughes RJ, Pepke-Zaba J, Coghlan JG.

Am J Respir Crit Care Med. 2009 Jan 15;179(2):151-7. doi: 10.1164/rccm.200806-953OC. Epub 2008 Oct 17.

PMID:
18931333
46.

The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension.

Elliot CA, Stewart P, Webster VJ, Mills GH, Hutchinson SP, Howarth ES, Bu'lock FA, Lawson RA, Armstrong IJ, Kiely DG.

Eur Respir J. 2005 Jul;26(1):168-73.

47.

Hormone replacement therapy acceptability to Nottingham post-menopausal women with a risk factor for osteoporosis.

Wallace WA, Price VH, Elliot CA, MacPherson MB, Scott BW.

J R Soc Med. 1990 Nov;83(11):699-701.

Supplemental Content

Loading ...
Support Center